Answer
Ataxia, peripheral neuropathy and somnolence have been reported during bendamustine treatment, and patients experiencing these symptoms should avoid driving, operating machinery and other potentially hazardous tasks.
Sources for this answer
- Bendamustine hydrochloride 180 mg/4 ml Concentrate For Solution For InfusionDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 8Document updated
Sources checked